Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02354118 · ClinicalTrials.gov registry record · NA
Maintaining Patency in Implanted Port Catheters
A NA study, sponsored by TriHealth.
- Completed
- Registry status
- NA
- Development phase
- 436
- Enrollment target
NCT02354118 is a NA study that has completed, run by TriHealth. The registered enrollment target is 436 participants.
The verdict
NCT02354118, a NA study, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 436 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safest and most effective flushing solution for maintaining patency (unobstructed flow) in implanted port catheters. The complication rate in patients whose ports are flushed with saline only will be compared to the complication rate in patients whose ports are flushed with a combination of saline and heparinized saline.
Interventions
- OTHER Heparinized saline catheter flush
- OTHER Saline-only catheter flush
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 436 participants |
| Start Date | 2013-01 |
| Est. Completion | 2021-12-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02354118
The ClinicalTrials.gov registry entry for NCT02354118 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 436 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Heparinized saline catheter flush is the first listed.
NCT02354118 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02354118 about?
NCT02354118 is a clinical study titled "Maintaining Patency in Implanted Port Catheters". The purpose of this study is to determine the safest and most effective flushing solution for maintaining patency (unobstructed flow) in implanted port catheters. The complication rate in patients whose ports are flushed with saline only will be compared to the complication rate in patients whose po...
What is the current status of trial NCT02354118?
This trial is currently completed. It is a NA study. The enrollment target is 436 participants. The study started on 2013-01. Estimated completion is 2021-12-17.
What interventions are being tested in trial NCT02354118?
The interventions under investigation include: Heparinized saline catheter flush (OTHER), Saline-only catheter flush (OTHER).
Who is sponsoring clinical trial NCT02354118?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.